These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 20010453

  • 21. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group.
    Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
    [Abstract] [Full Text] [Related]

  • 22. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study.
    Ladas ID, Kotsolis AI, Ladas DS, Niskopoulou M, Georgalas I, Papakonstantinou D, Rouvas AA.
    Retina; 2010 Sep; 30(8):1185-9. PubMed ID: 20539257
    [Abstract] [Full Text] [Related]

  • 23. Adverse events after intravitreal infliximab (Remicade).
    Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N.
    Retina; 2010 Jan; 30(1):71-80. PubMed ID: 19996827
    [Abstract] [Full Text] [Related]

  • 24. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization.
    Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, Piñero DP.
    Retina; 2010 Jan; 30(10):1609-15. PubMed ID: 20856171
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
    Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R.
    Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA, Chang KT, Liakopoulos S, Jivrajka RV, Walsh AC, Sadda SR.
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [Abstract] [Full Text] [Related]

  • 35. Primary intravitreal ranibizumab for myopic choroidial neovascularisation.
    Qureshi F, Saeed MU, Kamal A.
    Semin Ophthalmol; 2011 Mar; 26(2):52-4. PubMed ID: 21469965
    [Abstract] [Full Text] [Related]

  • 36. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
    Mimoun G, Caillaux V, Querques G, Rothschild PR, Puche N, Souied EH.
    Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
    [Abstract] [Full Text] [Related]

  • 37. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 38. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.
    Cho HJ, Kim CG, Yoo SJ, Cho SW, Lee DW, Kim JW, Lee JH.
    Am J Ophthalmol; 2013 Jan; 155(1):118-126.e1. PubMed ID: 23022163
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
    Pieramici DJ, Rabena M, Castellarin AA, Nasir M, See R, Norton T, Sanchez A, Risard S, Avery RL.
    Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.